Types of study to be included
No restrictions on study design although randomized studies will be weighted most heavily.
Condition or domain being studied
Schistosomiasis haematobia and schistosomiasis mansoni. Treatment coverage of total school-aged population, including non-enrolled school-aged children.
Participants/ population
Inclusion: School-aged children aged 5-15 not enrolled in school Exclusion: School-aged children 5-15 with no data about enrollment status
Intervention(s), exposure(s)
Interventions to be reviewed include school-based treatment with or without inclusion of non-enrolled children, community directed treatment regardless of modality (house-to-house, central location, or both), and integration of schistosomiasis treatment into existing control programs (such as onchocerciasis or lymphatic filariasis).
Studies will be excluded if they only have data on enrolled school-aged children.
Comparator(s)/ control
Comparator may be routine care or comparisons may be made between different treatment modalities. Routine care is defined as an area's existing method of schistosomiasis control whether that be passive treatment, surveillance, or some form of mass treatment.
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Context
Studies in population level control of schistosomiasis that target and include data on non-enrolled school-aged children. Only studies in English or French or in sub-Saharan Africa or regions with similar socioeconomic characteristics will be included.
Outcome(s)
Primary outcomes 1) Ratio of eligible non-enrolled school-aged children treated 2) Ratio of all eligible school-aged children treated
Number of eligible children treated may be measured by methods such as drug distribution record review or household survey. Total number of eligible children may be measured by methods such as household survey or community census.
Secondary outcomes 1) Where available, disease prevalence rates for the relevant populations, both before and after treatment. 
Data extraction, (selection and coding)
Titles and/or abstracts of articles identified with our search strategy will be reviewed by two independent researchers (MB, CK) to determine if they meet eligibility criteria. If there is any ambiguity, the full article will be reviewed. Disagreements will be resolved through consensus.
Extracted data will include study information, study site, study population and participant demographics, intervention type, type of Schistosoma species, prevalence before and after intervention, cost per child treated, census and evaluation methods, coverage, side effects, and operational obstacles.
Risk of bias (quality) assessment
Risk of bias assessment is not applicable.
Strategy for data synthesis
Data synthesis methods will be dependent on the number and quality of studies identified. Aggregate data will be used to estimate coverage efficacy of each intervention type, controlling for variations in local factors such as demographics and operational obstacles such as drug shortages, cultural resistance, or difficult geography.
Analysis of subgroups or subsets
If there are sufficient data, we will perform subgroup analyses based on initial infection prevalence, type and quality of study, and study setting.
Dissemination plans
We will produce brief written materials for stakeholders of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE). We will also submit a paper for publication in an open access journal and archive data and background materials at the SCORE website. 
Contact details for further information
